Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha
- PMID: 3498791
- PMCID: PMC2188710
- DOI: 10.1084/jem.166.4.991
Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha
Abstract
The immunoregulatory effects of transforming growth factor beta (TGF-beta) and recombinant murine tumor necrosis factor alpha (rMuTNF-alpha) on CTL generation and activity were examined. The results demonstrate that TGF-beta, in a dose-dependent manner, inhibited CTL generation but not CTL activity. The inhibitory effects were detected only when TGF-beta was added within the first 48 h of the MLC. Little activity was seen when it was added thereafter, including the addition of TGF-beta to the cytotoxicity assay. The production of TNF-alpha, which occurs during early phases of the MLC and which is inhibited in the presence of TGF-beta, appears to have an important regulatory role, as altering the levels of TNF-alpha in an MLC can significantly influence CTL development. The inhibitory effects of TGF-beta on the MLC can be significantly reversed by the addition of rMuTNF-alpha to the cultures. These results demonstrate that TGF-beta can inhibit MLC and subsequent CTL generation at early stages of the reaction, and such inhibition may involve the suppression of TNF-alpha production.
Similar articles
-
Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.Cancer Res. 1992 Mar 15;52(6):1386-92. Cancer Res. 1992. PMID: 1531782
-
Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.J Immunol. 1988 Apr 1;140(7):2312-6. J Immunol. 1988. PMID: 3280680
-
Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer splenic cells.J Immunol. 1996 Jun 1;156(11):4298-308. J Immunol. 1996. PMID: 8666801
-
Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.J Leukoc Biol. 2006 May;79(5):1033-42. doi: 10.1189/jlb.0805474. Epub 2006 Feb 14. J Leukoc Biol. 2006. PMID: 16478921
-
TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells.Immunology. 1989 Apr;66(4):570-6. Immunology. 1989. PMID: 2541074 Free PMC article.
Cited by
-
Update on the immunological pathway of negative regulation in acute insults and sepsis.J Interferon Cytokine Res. 2012 Jul;32(7):288-98. doi: 10.1089/jir.2011.0117. Epub 2012 Apr 17. J Interferon Cytokine Res. 2012. PMID: 22509978 Free PMC article. Review.
-
Transforming growth factor beta is protective in host resistance against Listeria monocytogenes infection in mice.Infect Immun. 1996 Sep;64(9):3901-4. doi: 10.1128/iai.64.9.3901-3904.1996. Infect Immun. 1996. PMID: 8751946 Free PMC article.
-
Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains.Infect Immun. 1998 May;66(5):2213-20. doi: 10.1128/IAI.66.5.2213-2220.1998. Infect Immun. 1998. PMID: 9573110 Free PMC article.
-
T-cell Exhaustion and Cancer Immunotherapy.J Int Oral Health. 2015 Aug;7(8):i-ii. J Int Oral Health. 2015. PMID: 26464560 Free PMC article. No abstract available.
-
Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression.J Clin Immunol. 1991 Mar;11(2):95-102. doi: 10.1007/BF00917745. J Clin Immunol. 1991. PMID: 1905306
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources